+44 115 7870500
DevelRx Logo
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact

Scientific Articles - Psychiatric and Neurological Disorders

Drug Abuse and DependenceADHDBinge-Eating DisorderPsychiatric and Neurological DisordersObesity and Metabolic Disorders

Stanford SC, Heal DJ. Catecholamines: Knowledge and understanding in the 1960s, now, and in the future. Brain Neurosci Adv, 2019; 3: 2398212818810682.

Hutson PH, Rowley HL, Gosden J, Kulkarni RS, Slater N, Love PL, Wang Y, Heal D. The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a d-amphetamine cue. Neuropharmacol, 2016; 10: 24-35.

Smith SL, Heal DJ and Martin KF. KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev, 2005; 11: 113-140.

Smith SL, Thompson KSJ, Sargent BJ and Heal DJ. BTS 72 664 - A novel CNS drug with potential anticonvulsant, neuroprotective and antimigraine properties. CNS Drug Rev, 2001; 7: 146-171.

Cheetham SC and Heal DJ. Antidepressant and anxiolytic drugs. In: Principles of Medical Biology, Vol 14B. Eds: Bitar N and Bittar EE. pp 509-565. JAI Press, Stamford, 2000.

Heal DJ and Cheetham SC. SSRIs: Where now, where next? In: SSRIs: Past, Present and Future. Ed: Stanford SC. pp 189-220. RG Landes Company, Georgetown, 2000.

Rowley HL, Needham PL, Kilpatrick IC and Heal DJ. A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmiedeberg’s Arch Pharmac, 2000; 361: 187-192.

Heal DJ, Czudek C and Buckett WR. Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by dopamine turnover studies. Prog. Neuro-Psychopharmacol. Biol Psychiat, 1994; 18: 803-821.

Heal DJ, Luscombe GP and Martin KF. Pharmacological identification of 5-HT receptor subtypes using behavioural models. In: Central Serotonin Receptors and Psychotropic Drugs. Eds. Marsden CA and Heal DJ. pp 56-99. Blackwell Scientific, Oxford, 1992.

Heal DJ. The effects of drugs on behavioural models of central noradrenergic function. In: The Pharmacology of Noradrenaline in the Central Nervous System. Eds: Heal DJ and Marsden CA. pp. 266-315. Oxford University Press, Oxford. 1990.

Green AR and Heal DJ. Effects of drugs on serotonin-mediated behavioural models. In: Neuropharmacology of Serotonin. Ed: Green AR. pp 326-365. Oxford University Press, Oxford, 1985

DevelRx Logo


Pennyfoot Street,





Cookie PolicyPrivacy PolicyTerms & Conditions

Registered in England and Wales

Company number: 12028847